Literature DB >> 19507213

Myeloid neighborhood in myeloma: cancer's underbelly?

Madhav V Dhodapkar.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19507213      PMCID： PMC2752050          DOI： 10.1002/ajh.21460

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  17 in total

1.  Bortezomib disrupts tumour-dendritic cell interactions in myeloma and lymphoma: therapeutic implications.

Authors:  Anjli Kukreja; Aisha Hutchinson; Amitabha Mazumder; David Vesole; Revathi Angitapalli; Sundar Jagannath; Owen A O'connor; Madhav V Dhodapkar
Journal:  Br J Haematol       Date:  2007-01       Impact factor: 6.998

2.  Circulating endothelial progenitor cells in multiple myeloma: implications and significance.

Authors:  Hong Zhang; Varsha Vakil; Marc Braunstein; Eric L P Smith; Justin Maroney; Laurie Chen; Kezhi Dai; James R Berenson; M Mahmood Hussain; Uwe Klueppelberg; Allen J Norin; Hasan O Akman; Tayfun Ozçelik; Olcay A Batuman
Journal:  Blood       Date:  2004-12-23       Impact factor: 22.113

Review 3.  Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.

Authors:  John Condeelis; Jeffrey W Pollard
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

4.  Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma.

Authors:  J W Said; M R Rettig; K Heppner; R A Vescio; G Schiller; H J Ma; D Belson; A Savage; I P Shintaku; H P Koeffler; H Asou; G Pinkus; J Pinkus; M Schrage; E Green; J R Berenson
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

5.  Primary antitumor immune response mediated by CD4+ T cells.

Authors:  Alexandre Corthay; Dag K Skovseth; Katrin U Lundin; Egil Røsjø; Hilde Omholt; Peter O Hofgaard; Guttorm Haraldsen; Bjarne Bogen
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

Review 6.  Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies.

Authors:  Claire Lewis; Craig Murdoch
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

7.  CD28-mediated regulation of multiple myeloma cell proliferation and survival.

Authors:  Nizar J Bahlis; Anne M King; Despina Kolonias; Louise M Carlson; Hong Yu Liu; Mohamad A Hussein; Howard R Terebelo; Gerald E Byrne; Bruce L Levine; Lawrence H Boise; Kelvin P Lee
Journal:  Blood       Date:  2007-02-20       Impact factor: 22.113

8.  Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells.

Authors:  D Chauhan; A Bharti; N Raje; E Gustafson; G S Pinkus; J L Pinkus; G Teoh; T Hideshima; S P Treon; J D Fingeroth; K C Anderson
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

Review 9.  Interactions of tumor cells with dendritic cells: balancing immunity and tolerance.

Authors:  M V Dhodapkar; K M Dhodapkar; A K Palucka
Journal:  Cell Death Differ       Date:  2007-10-19       Impact factor: 15.828

10.  Enhancement of clonogenicity of human multiple myeloma by dendritic cells.

Authors:  Anjli Kukreja; Aisha Hutchinson; Kavita Dhodapkar; Amitabha Mazumder; David Vesole; Revathi Angitapalli; Sundar Jagannath; Madhav V Dhodapkar
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307
View more
  2 in total

1.  Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.

Authors:  Anjli Kukreja; Soroosh Radfar; Ben-Hua Sun; Karl Insogna; Madhav V Dhodapkar
Journal:  Blood       Date:  2009-08-06       Impact factor: 22.113

Review 2.  Staging and prognostication of multiple myeloma.

Authors:  Rafael Fonseca; Jorge Monge; Meletios A Dimopoulos
Journal:  Expert Rev Hematol       Date:  2014-02       Impact factor: 2.929
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.